DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Barata PC, De Liano AG, Mendiratta P. et al.
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma.
Br J Cancer 2018;
119: 160-163
DOI: 10.1038/s41416-018-0104-z.
We do not assume any responsibility for the contents of the web pages of other providers.